Metoprololtartrat Al

Metoprolol tartrate, the active ingredient in Metoprololtartrat Al, is a beta blocker presented as an oral tablet for oral use. It lowers blood pressure and heart rate, reducing cardiac workload in patients with hypertension, angina, heart failure, and other cardiovascular conditions.

GNH USA supplies Metoprololtartrat Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Metoprolol tartrate is used to manage several cardiovascular disorders by modulating beta‑adrenergic activity.

- Hypertension: reduces systolic and diastolic pressure to lower cardiovascular risk. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Heart failure: improves ventricular function and reduces hospitalisation rates. - Post‑myocardial infarction prophylaxis: lowers the chance of recurrent cardiac events. - Cardiac arrhythmias: stabilises heart rhythm by slowing conduction through the AV node.

Metoprolol tartrate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Fatigue or general weakness - Dizziness or light‑headedness - Cold extremities (hands and feet) - Bradycardia (slow heart rate) - Gastrointestinal upset (nausea, abdominal discomfort) - Sleep disturbances (insomnia or vivid dreams)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma or COPD - Depression or mood changes - Allergic reactions (rash, angioedema, anaphylaxis) - Cardiogenic shock in extreme cases

Before initiating therapy, consider the following precautions.

- Dose adjustment in renal impairment: reduce dose according to renal function. - Monitor heart rate and blood pressure: check regularly during initiation and dose changes. - Avoid abrupt discontinuation: taper under medical supervision to prevent rebound hypertension. - Caution in asthma or COPD: may exacerbate bronchospasm. - Store at below 25°C: keep in the original container, protect from moisture.

Metoprolol tartrate can interact with several drug classes; awareness helps minimise risk.

Major Interactions (Avoid): - Concomitant use with non‑selective beta blockers: additive bradycardia. - Combination with calcium‑channel blockers (verapamil, diltiazem): risk of severe AV block. - Concurrent use with potent CYP2D6 inhibitors (e.g., quinidine, paroxetine): may increase plasma levels.

Moderate Interactions (Monitor Closely): - Co‑administration with diuretics: may enhance hypotensive effect. - Use with antidiabetic agents: may mask hypoglycaemia symptoms. - Interaction with NSAIDs: may reduce antihypertensive efficacy.